Germany - Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by All Financing Schemes
Since 2014, Germany Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by All Financing Schemes increased 3.2% year on year. In 2019, the country was number 3 comparing other countries in Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by All Financing Schemes at €668.01 Per Capita. Germany is overtaken by Liechtenstein, which was number 2 with €860.32 Per Capita and is followed by Belgium with €606.09 Per Capita. Switzerland ranked the highest with €1,048.7 Per Capita in 2019, that is +2.6% compared to 2018. Latvia recorded the best 5 years average growth at +7.4% per year, while Greece witnessed the worst performance at -0.5% per year.
Loading...
| Date | Euros Per Capita |
|---|---|
| 2019 | 668.01 |
| 2018 | 656.99 |
| 2017 | 634.95 |
| 2016 | 615.99 |
| 2015 | 593.89 |
Download all data from 1992 to 2019
How does Germany rank in Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by All Financing Schemes?
| # | 33 Countries | Euros Per Capita | Last | YoY | 5‑years CAGR | |
|---|---|---|---|---|---|---|
| 1 |
#1
Switzerland
|
1,048.70 | 2019 | +2.6 % | +4.7 % | View data |
| 2 |
#2
Liechtenstein
|
860.32 | 2019 | +3.0 % | +2.4 % | View data |
| 3 |
#3
Germany
|
668.01 | 2019 | +1.7 % | +3.2 % | View data |
| 4 |
#4
Belgium
|
606.09 | 2019 | +0.1 % | +2.9 % | View data |
| 5 |
#5
Luxembourg
|
593.97 | 2019 | +0.9 % | +0.8 % | View data |